SCYX
Scynexis IncNASDAQ
Healthcare • Drug Manufacturers - Specialty & Generic
Updated 1 day ago
Coverage limited
$3.99-0.99%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -13.3%
- 3 months
- -17.4%
- 1 year
- -35.2%
- Dividend
- No dividends on record
- Short interest
- 8.1% of float594.3K shares · settled Sep 30, 2026 · +29.3% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $19.22M
- Net income
- -$10.24M
- Free cash flow
- -$13.31M
- Book value
- $66.93M
- Total debt
- $1.95M
- P/E
- —
- Price / sales
- —
- Price / book
- —
- FCF yield
- —
- Net margin
- -53.3%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if SCYX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
12 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
40 filers reported a long position in SCYX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-06-01 1-for-8 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | $3.8M | 944.3K | 0% |
| Squadron Capital Management LLC | $3.1M | 756.9K | -20.4% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.2M | 543.5K | New |
| Propel Bio Management, LLC | $2.2M | 543.5K | New |
| Woodline Partners LP | $1.6M | 387.5K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | 296.7K | +51.8% |
| Avidity Partners Management LP | $1.1M | 260.2K | 0% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $1M | 247.8K | 0% |
| MILLENNIUM MANAGEMENT LLC | $735.8K | 180.8K | +132.5% |
| HEIGHTS CAPITAL MANAGEMENT, INC | $612.7K | 150.6K | -42.3% |
Get the Full Analysis for SCYX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.